About us
Building the future of cell-specific cancer therapies
A Proprietary Data Advantage
Allowing us to derive unique insights from our massive and fully-integrated dataset of over 15M tumor and healthy cells.
A Powerful Therapeutic Engine
Leveraging cellular genomics, antibody engineering, and computational biology to translate targets into therapeutics.
what we do
Cartography is a therapeutics company building a differentiated pipeline of antibody-based therapies more precise than existing therapies.
from
data
analyzing
Single cell sequencing to document target expression across all relevant cell types.
selecting
Target selection based on tumor expression, off-target impact, and market dynamics.
prediction
Program definition based on likelihood of success and ideal patient population.
designing
Antibody and binder design that optimizes for targeting single or paired targets.
to
drugs
machine learning
artificial intelligence
computational biology
mission and values
Building a next generation drug discovery engine to widen the world of treatable cancers. We’re bridging the world of immunology and computation, to build a smarter roadmap for cancer therapies.
Boldly ambitious,
laser focused
We set big goals, make a plan, and achieve them.
Transparent
communication
The better we communicate with each other, the better we will work together.
Patients
First
Throughout our values, we remember that patients are at the core of everything we do.
United we thrive
We maintain a culture of respect and kindness, where courtesy and consideration for others are fundamental.
Collective ownership
We hold ourselves and each other accountable by lending a hand to carry the load.
Join our team of pioneers
Expand the reach of next-generation cancer therapies by working with us to make them more precise, more effective and more accessible for patients everywhere.